Summary slide.png (64.17 kB)

Idarucizumab Reverses Dabigatran Anticoagulant Activity in Healthy Chinese Volunteers: A Pharmacokinetics, Pharmacodynamics and Safety Study

media

posted on 16.07.2020, 15:41 by Zining Wang, Xia Zhao, Pengkang He, Shuqing Chen, Jie Jiang, Akiko Harada, Steven Brooks, Yimin Cui

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s12325-020-01439-2

Usage metrics

Read the peer-reviewed publication

Idarucizumab Reverses Dabigatran Anticoagulant Activity in Healthy Chinese Volunteers: A Pharmacokinetics, Pharmacodynamics and Safety Study

Advances in Therapy

Keywords

Dabigatran etexilate Healthy Chinese subjects Idarucizumab Pharmacokinetic/pharmacodynamic Safety

Licence

CC BY-NC 4.0

Idarucizumab Reverses Dabigatran Anticoagulant Activity in Healthy Chinese Volunteers: A Pharmacokinetics, Pharmacodynamics and Safety Study

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports